A pilot survey was carried out in two countries (Slovenia, Lithuania) to validate the questions in terms of clarity, after which the refined questionnaire was sent out to experts of different European countries with knowledge of the biosimilar market.
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}